Mark A. Gregory
- Hematology top 5%
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 4
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 2
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 6
- Cell death mechanisms and regulation 5
- Histone Deacetylase Inhibitors Research 4
- Oncology top 5%
- Cancer-related Molecular Pathways 5
- Genetics top 10%
-
- Eosinophilic Disorders and Syndromes 2
- Co-authors
- Stephan HannYing QiJulie A. VranaAaron M. DominaRuth W. CraigJames DeGregoriVadym ZaberezhnyyJeffrey P. Brousal
- Journals
- Clinical Cancer Research (3 papers)Oncogene (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesUkraineSpain
In The Last Decade
Mark A. Gregory
21 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 80
- Hematology 335
- Cancer Research 360
- Molecular Biology 1.5k
- Oncology 567
- Genetics 141
Countries citing papers authored by Mark A. Gregory
This map shows the geographic impact of Mark A. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Gregory more than expected).
Fields of papers citing papers by Mark A. Gregory
This network shows the impact of papers produced by Mark A. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Gregory. The network helps show where Mark A. Gregory may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark A. Gregory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 18 | |
| 3 | 2021 | 1 | |
| 4 | 2019 | 127 | |
| 5 | 2017 | 65 | |
| 6 | 2016 | 81 | |
| 7 | 2014 | 56 | |
| 8 | 2014 | 12 | |
| 9 | 2013 | 58 | |
| 10 | 2012 | 11 | |
| 11 | 2012 | 37 | |
| 12 | 2012 | 33 | |
| 13 | 2010 | 141 | |
| 14 | 2010 | 1 | |
| 15 | 2004 | 255 | |
| 16 | 2004 | 172 | |
| 17 | 2003 | 357 | |
| 18 | 2000 | 34 | |
| 19 | 2000 | 16 | |
| 20 | 2000 | 375 |
About Mark A. Gregory
Mark A. Gregory is a scholar working on Hematology, Oncology and Cancer Research, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Ubiquitin and proteasome pathways (6 papers), Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Hematology (335 citations), Cancer Research (360 citations) and Molecular Biology (1.5k citations). Mark A. Gregory has collaborated with scholars based in United States, Ukraine and Spain. Frequent co-authors include Stephan Hann, Ying Qi, Julie A. Vrana, Aaron M. Domina, Ruth W. Craig, James DeGregori, Vadym Zaberezhnyy, Ying Qi, Jeffrey P. Brousal and Kirk C. Hansen. Their work appears in journals such as Clinical Cancer Research, Oncogene, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.